When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation

被引：0
|
作者：
James Weatherall
William H. Polonsky
Sally Lanar
Naomi Knoble
Jonas Håkan-Bloch
Elisabeth Constam
Athena Philis-Tsimikas
Alexia Marrel
机构：
[1] Novo Nordisk Inc,
[2] Behavioral Diabetes Institute,undefined
[3] University of California,undefined
[4] Mapi Group,undefined
[5] Mapi Group,undefined
[6] Novo Nordisk A/S,undefined
[7] Scripps Whittier Diabetes Institute,undefined
来源：
Health and Quality of Life Outcomes | / 16卷
关键词：
Insulin degludec; Type 2 diabetes; Health-related quality of life; Patient interviews; Patient focus groups, qualitative research;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation
    Weatherall, James
    Polonsky, William H.
    Lanar, Sally
    Knoble, Naomi
    Hakan-Bloch, Jonas
    Constam, Elisabeth
    Philis-Tsimikas, Athena
    Marrel, Alexia
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2018, 16
  • [2] Qualitative Assessment of the Impact of Insulin Degludec on Quality of Life in Patients with Type 2 Diabetes
    Polonsky, William
    Lanar, Sally
    Knoble, Naomi
    Weatherall, James
    Hakan-Bloch, Jonas
    Constam, Elisabeth
    Philis-Tsimikas, Athena
    Marrel, Alexia
    DIABETES, 2017, 66 : A212 - A213
  • [3] Insulin degludec: Effects on Quality of Life in Type 2 Diabetes
    Kulzer, B.
    Wilhelm, B.
    Hermanns, N.
    DIABETES STOFFWECHSEL UND HERZ, 2015, 24 (04): : 241 - 249
  • [4] Effect of switching basal insulin regimen to degludec on quality of life in Japanese patients with type 1 and type 2 diabetes mellitus
    Okada M.
    Okada M.
    Nishigami J.
    Yamaaki N.
    Furukawa K.
    Ohyama K.
    Shimada T.
    Sai Y.
    Journal of Pharmaceutical Health Care and Sciences, 1 (1)
  • [5] Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes
    Oya, Junko
    Nakagami, Tomoko
    Hasegawa, Yukiko
    Kondo, Yuichiro
    Katamine, Aki
    Shimizu, Mika
    Kubota, Ryo
    Suda, Rika
    Babazono, Tetsuya
    DIABETOLOGY INTERNATIONAL, 2024, 15 (02) : 237 - 243
  • [6] Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes
    Junko Oya
    Tomoko Nakagami
    Yukiko Hasegawa
    Yuichiro Kondo
    Aki Katamine
    Mika Shimizu
    Ryo Kubota
    Rika Suda
    Tetsuya Babazono
    Diabetology International, 2024, 15 : 237 - 243
  • [7] The Influence of Insulin Degludec on Type 2 Diabetes Mellitus Regulation and Patient Quality of Life Compared with Insulin Glargine in Low-Income Patients
    Koutsovasilis, Anastasios
    Sotiropoulos, Alexios
    Pappa, Maria
    Bousboulas, Stavros
    Peppas, Theodoros
    DIABETES, 2020, 69
  • [8] Quality of life in patients with type 2 diabetes after switching to insulin degludec: results from a cross-sectional survey
    Chioma Uzoigwe
    Michael Radin
    Carol M. Hamersky
    Mitch DeKoven
    Cassie Holt
    Swapna Karkare
    William H. Polonsky
    Quality of Life Research, 2021, 30 : 1629 - 1640
  • [9] Quality of life in patients with type 2 diabetes after switching to insulin degludec: results from a cross-sectional survey
    Uzoigwe, Chioma
    Radin, Michael
    Hamersky, Carol M.
    DeKoven, Mitch
    Holt, Cassie
    Karkare, Swapna
    Polonsky, William H.
    QUALITY OF LIFE RESEARCH, 2021, 30 (06) : 1629 - 1640
  • [10] Comparison of Insulin Glargine with Insulin Degludec in Type 1 Diabetes Patients
    Kuroda, Akio
    Tsuruo, Miho
    Takeshi, Kondo
    Aki, Nanako
    Oguro, Yukari
    Endo, Itsuro
    Aihara, Ken-ichi
    Tamaki, Motoyuki
    Matsumoto, Toshio
    Matsuhisa, Munehide
    DIABETES, 2014, 63 : A232 - A232
12345